Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Chinese Patent Office
Queensland Health
Accenture
Cipla
US Department of Justice
Baxter
Novartis
Chubb
AstraZeneca

Generated: August 17, 2017

DrugPatentWatch Database Preview

OXYMORPHONE HYDROCHLORIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Oxymorphone Hydrochloride, and when can generic versions of Oxymorphone Hydrochloride launch?

Oxymorphone Hydrochloride is a drug marketed by Avanthi Inc, Sun Pharm Inds Ltd, Mallinckrodt Inc, West-ward Pharms Int, Teva, Actavis Elizabeth, Aurolife Pharma Llc, Impax Labs, Epic Pharma Llc, and Par Pharm. and is included in twelve NDAs.

The generic ingredient in OXYMORPHONE HYDROCHLORIDE is oxymorphone hydrochloride. There are nine drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the oxymorphone hydrochloride profile page.

Summary for Tradename: OXYMORPHONE HYDROCHLORIDE

Patents:0
Applicants:10
NDAs:12
Suppliers / Packagers: see list11
Bulk Api Vendors: see list18
Clinical Trials: see list2,276
Patent Applications: see list4,690
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:OXYMORPHONE HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: OXYMORPHONE HYDROCHLORIDE

Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Impax Labs
OXYMORPHONE HYDROCHLORIDE
oxymorphone hydrochloride
TABLET, EXTENDED RELEASE;ORAL079087-003Jun 14, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Mallinckrodt Inc
OXYMORPHONE HYDROCHLORIDE
oxymorphone hydrochloride
TABLET, EXTENDED RELEASE;ORAL202946-005Jun 27, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Par Pharm
OXYMORPHONE HYDROCHLORIDE
oxymorphone hydrochloride
TABLET, EXTENDED RELEASE;ORAL200792-002Oct 24, 2014DISCNNoNo► Subscribe► Subscribe► Subscribe
Impax Labs
OXYMORPHONE HYDROCHLORIDE
oxymorphone hydrochloride
TABLET, EXTENDED RELEASE;ORAL079087-007Jun 14, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Par Pharm
OXYMORPHONE HYDROCHLORIDE
oxymorphone hydrochloride
TABLET, EXTENDED RELEASE;ORAL200792-003Oct 24, 2014DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Queensland Health
AstraZeneca
Fish and Richardson
UBS
Medtronic
Farmers Insurance
US Army
Deloitte
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot